James Hassard Crinetics Pharmaceuticals, Inc. (CRNX) insider trading activity

CRNX Quotes by TradingView

James Hassard is Chief Commercial Officer of Crinetics Pharmaceuticals, Inc.. Currently has a direct ownership of 29,259 shares of CRNX, which is worth approximately $1.31 Million. The most recent transaction as insider was on Jun 21, 2024, when has been sold 15,000 shares (Common Stock) at a price of $44.66 per share, resulting in proceeds of $669,900. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 29.3K
0% 3M change
108.99% 12M change
Total Value Held $1.31 Million

James Hassard Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 21 2024
SELL
Open market or private sale
$669,900 $44.66 p/Share
15,000 Reduced 33.89%
29,259 Common Stock
Jun 21 2024
BUY
Exercise of conversion of derivative security
$295,950 $19.73 p/Share
15,000 Added 25.31%
44,259 Common Stock
Mar 18 2024
SELL
Payment of exercise price or tax liability
$66,401 $38.14 p/Share
1,741 Reduced 5.62%
29,259 Common Stock
Mar 04 2024
BUY
Grant, award, or other acquisition
-
17,000 Added 35.42%
31,000 Common Stock
Mar 01 2023
BUY
Grant, award, or other acquisition
-
14,000 Added 50.0%
14,000 Common Stock

Also insider at

ARWR
ARROWHEAD PHARMACEUTICALS, INC. Healthcare
Chief Commercial Officer
JH

James Hassard

Chief Commercial Officer
San Diego, CA

Track Institutional and Insider Activities on CRNX

Follow Crinetics Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRNX shares.

Notify only if

Insider Trading

Get notified when an Crinetics Pharmaceuticals, Inc. insider buys or sells CRNX shares.

Notify only if

News

Receive news related to Crinetics Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CRNX